From FDA-approved daily pills like the Wegovy® tablet and new Foundayo™ to compounded sublingual drops and dissolvable tablets, we compare every oral GLP-1 option that actually works — and flag the ones that don't.
Guides, research, and insights from Oral GLP
23 articlesNot all weight loss pills are GLP-1s. Here's how the Wegovy pill stacks up against older oral options — and when those alternatives might still make sense.
Real 5-year cost math for every oral GLP-1 option in 2026. Wegovy pill, Rybelsus, Foundayo, compounded semaglutide. With insurance. Without insurance. What the total actually adds
The complete reference: every FDA warning letter issued to telehealth compounded GLP-1 companies in 2026. Dates, letter numbers, violations, and what each means for consumers.
Eli Lilly holds the patents on tirzepatide. They had every reason to make an oral version. Instead they invented a different molecule entirely. Here's why that matters for anyone b
Rybelsus bioavailability is 0.4-1%. The science of why most of your oral semaglutide pill never works, why the fasting protocol exists, and what this means for compounded alternati
Oral semaglutide has specific dosing requirements that directly affect how much medication your body absorbs. Here's the protocol, why it matters, and what happens when you skip st
A clear pharmacology explainer for non-specialists: what GLP-1 is, how the medications mimic it, and why it took so long to make an oral version that works.
A complete guide to Foundayo (orforglipron): how the first small-molecule oral GLP-1 works, ATTAIN-1 trial results, dosing, pricing via LillyDirect, and how it compares to Wegovy p
An honest review of Wellorithm's $147/month compounded semaglutide program. Pricing, billing terms, clinical model, and how it compares to our recommended alternatives.
A detailed review of Strut Health's compounded GLP-1 program after the February 2026 FDA warning letter. What the letter said, what Strut has done since, and alternatives worth con
A detailed review of Sprout Health's orally disintegrating tablet (ODT) compounded GLP-1 program. Pricing, clinical model, regulatory standing, and how it compares to alternatives.
A combined review of SkinnyRx and 24hrDoc after both received February 2026 FDA warning letters. What the violations were, what changed, and which alternatives we recommend instead
A transparent review of MEDVi's compounded GLP-1 program — including the February 2026 FDA warning letter, the OpenLoop data breach, and what safer alternatives exist.
An honest evidence review of sublingual compounded semaglutide. Pharmacology, published studies, the marketing-vs-evidence gap, and how to evaluate providers.
A plain-English guide to oral GLP-1 insurance coverage in 2026. Rybelsus, Wegovy pill, Foundayo. Prior authorization, manufacturer savings cards, and how to appeal denials.
A practical 90-day guide to starting an oral GLP-1. What to expect week by week, how to manage side effects, dose titration, and red flags that matter.
The cheapest oral GLP-1 options in 2026 compared honestly. FDA-approved and compounded pricing, insurance paths, hidden costs, and how to find real value.
Honest Care Bare Rx review. $199/month bundled oral GLP-1 program with HSA/FSA acceptance and 50-state coverage. Pricing, program structure, and who it fits.
Honest SHED review. Four compounded oral formats plus brand Wegovy pill access. Pricing, accreditations, 10% weight-loss guarantee, and how SHED compares.
Sesame Care review for oral GLP-1. Novo Nordisk Recognized Care Provider. Get Wegovy pill at $149/month through FDA-approved medications only.
Oral semaglutide (Wegovy pill) vs injectable semaglutide (Wegovy) compared honestly. OASIS 4 vs STEP 1 trial data, cost, convenience, and which is right for you.
Every oral GLP-1 option in 2026 compared: FDA-approved Wegovy pill, Foundayo, Rybelsus, plus compounded alternatives. Efficacy, cost, and who should consider each.
Honest MangoRx Slim review. Compounded semaglutide ODT from a publicly-traded company. Pricing, pharmacy partner, dosing flexibility, and how it compares to alternatives.
No articles found matching your search.